Shenyang Xingqi Pharmaceutical Co.,Ltd. (China)

Shenyang Xingqi Pharmaceutical Co., Ltd is a national high-tech enterprise located in Shenyang, China. The company specializes in the research, production, and sales of ophthalmic drugs. It was incorporated on December 8, 2016, and is listed on the Shenzhen Stock Exchange's Growth Enterprise Market with the stock code 300573. In 2022, the company was awarded the Silver Award of the 9th Liaoning Provincial Governor's Quality Award. Shenyang Xingqi Pharmaceutical Co., Ltd is guided by the mission of "operating health, creating brightness" and the vision of becoming a globally competitive ophthalmic drug research and manufacturing company. The company values persistence, innovation, responsibility, and win-win cooperation. It is actively involved in the human eye health industry. The company's product portfolio includes various categories of ophthalmic drugs such as anti-infective drugs, anti-inflammatory/anti-infective drugs, artificial tears and lubricants, dry eye treatment drugs, nutrition and corneal repair drugs, mydriatics and cycloplegics, non-steroidal anti-inflammatory drugs, miotics and antiglaucoma drugs, and intraocular irrigation solutions. These products provide high-quality solutions for the treatment of ophthalmic diseases. Shenyang Xingqi Pharmaceutical Co., Ltd has established research platforms for ophthalmic drug development, including conventional ophthalmic formulations, instant gels, sustained-release formulations, ophthalmic GLP laboratories, and pharmaceutical packaging materials. The company has comprehensive capabilities for ophthalmic drug research and innovation. In October 2020, the company's quality testing center obtained CNAS accreditation from the China National Accreditation Service for Conformity Assessment, demonstrating its ability to conduct experimental testing according to accredited criteria. The company's Chessboard Mountain factory, which was put into operation in 2014, adheres to the design standards of the US FDA cGMP and EU GMP. It is equipped with multiple production lines that meet domestic GMP standards, including extraction production lines, single-dose eye drop production lines, multi-dose eye drop production lines, ophthalmic gel production lines, ophthalmic solution production lines, and ophthalmic packaging material production lines. Shenyang Xingqi Pharmaceutical Co., Ltd focuses on market-oriented research and development and production of ophthalmic drugs. It collaborates closely with domestic and international research institutes, medical institutions, and ophthalmic experts to promote the transformation of scientific research achievements. The company also utilizes professional academic promotion to lead market sales. Through an improved marketing system, it establishes cooperative relationships with distributors at various levels, covering medical institutions at the provincial, city, and county levels nationwide. Shenyang Xingqi Pharmaceutical Co., Ltd strives to create long-term value for customers, employees, shareholders, partners, and society. It is dedicated to promoting traditional Chinese medicine while continuously improving itself. The company remains committed to its vision of becoming a globally competitive ophthalmic drug research and manufacturing company.